Oromandibular Dystonia Treatment With Aripiprazole in an Adolescent Patient 2-Year Follow-Up: A Case Report

Gümüş Y. Y., SAY G. N.

PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, cilt.31, sa.3, ss.358-360, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 31 Sayı: 3
  • Basım Tarihi: 2021
  • Doi Numarası: 10.5152/pcp.2021.21068
  • Dergi Adı: PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.358-360
  • Anahtar Kelimeler: Adolescent, aripiprazole, dystonia treatment, oromandibular dystonia (OMD), TARDIVE-DYSKINESIA, DIAGNOSIS
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Oromandibular dystonia (OMD) is a movement disorder that can cause considerable functional and psychosocial disability such as dysphagia, dysarthria, breathing difficulty, weight loss, social withdrawal, and depression. Oromandibular dystonia has no known cure. Many different treatment approaches can be used for the treatment of OMD. In this case report, we present a 16-year-old female adolescent patient with OMD, who showed a significant improvement with the use of 5 mg/day aripiprazole during the 2-year follow-up.